130 related articles for article (PubMed ID: 37666656)
1. Predicting residual neoplasia after a non-curative gastric ESD: validation and modification of the eCura system in the Western setting: the W-eCura score.
Morais R; Libanio D; Dinis Ribeiro M; Ferreira A; Barreiro P; Bourke MJ; Gupta S; Amaro P; Küttner Magalhães R; Cecinato P; Boal Carvalho P; Pinho R; Rodríguez de Santiago E; Sferrazza S; Lemmers A; Figueiredo M; Pioche M; Gallego F; Albéniz E; Ramos Zabala F; Uchima H; Berr F; Wagner A; Marques M; Pimentel-Nunes P; Gonçalves M; Mascarenhas A; Soares EG; Xavier S; Faria-Ramos I; Sousa-Pinto B; Gullo I; Carneiro F; Macedo G; Santos-Antunes J
Gut; 2023 Dec; 73(1):105-117. PubMed ID: 37666656
[TBL] [Abstract][Full Text] [Related]
2. The eCura system as a novel indicator for the necessity of salvage surgery after non-curative ESD for gastric cancer: A case-control study.
Niwa H; Ozawa R; Kurahashi Y; Kumamoto T; Nakanishi Y; Okumura K; Matsuda I; Ishida Y; Hirota S; Shinohara H
PLoS One; 2018; 13(10):e0204039. PubMed ID: 30273388
[TBL] [Abstract][Full Text] [Related]
3. Decision to perform additional surgery after non-curative endoscopic submucosal dissection for gastric cancer based on the risk of lymph node metastasis: a long-term follow-up study.
Lee S; Kim SG; Cho SJ
Surg Endosc; 2023 Oct; 37(10):7738-7748. PubMed ID: 37567980
[TBL] [Abstract][Full Text] [Related]
4. Determination of Additional Surgery after Non-Curative Endoscopic Submucosal Dissection in Patients with Early Gastric Cancer: A Practically Modified Application of the eCura System.
Lee S; Song JH; Park SH; Cho M; Kim YM; Kim HI; Hyung WJ
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830922
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of the application of the curative criteria of the 5
Chen Z; Liu Y; Dou L; Zhang Y; He S; Wang G
Saudi J Gastroenterol; 2021; 27(2):97-104. PubMed ID: 33642353
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of endoscopic treatment and predictors of lymph node metastasis in early gastric cancer.
Chu YN; Yu YN; Jing X; Mao T; Chen YQ; Zhou XB; Song W; Zhao XZ; Tian ZB
World J Gastroenterol; 2019 Sep; 25(35):5344-5355. PubMed ID: 31558878
[TBL] [Abstract][Full Text] [Related]
7. A Scoring System to Stratify Curability after Endoscopic Submucosal Dissection for Early Gastric Cancer: "eCura system".
Hatta W; Gotoda T; Oyama T; Kawata N; Takahashi A; Yoshifuku Y; Hoteya S; Nakagawa M; Hirano M; Esaki M; Matsuda M; Ohnita K; Yamanouchi K; Yoshida M; Dohi O; Takada J; Tanaka K; Yamada S; Tsuji T; Ito H; Hayashi Y; Nakaya N; Nakamura T; Shimosegawa T
Am J Gastroenterol; 2017 Jun; 112(6):874-881. PubMed ID: 28397873
[TBL] [Abstract][Full Text] [Related]
8. Additional laparoscopic gastrectomy after noncurative endoscopic submucosal dissection for early gastric cancer: A single-center experience.
Tian YT; Ma FH; Wang GQ; Zhang YM; Dou LZ; Xie YB; Zhong YX; Chen YT; Xu Q; Zhao DB
World J Gastroenterol; 2019 Aug; 25(29):3996-4006. PubMed ID: 31413533
[TBL] [Abstract][Full Text] [Related]
9. Indication for endoscopic treatment based on the risk of lymph node metastasis in patients with undifferentiated early gastric cancer.
Liang XQ; Wang Z; Li HT; Ma G; Yu WW; Zhou HC; Liu HB
Asian J Surg; 2020 Oct; 43(10):973-977. PubMed ID: 31964584
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathological Examination of 81 Cases Added Gastrectomy for Early Gastric Cancer after ESD].
Itoh N; Miyoshi T; Hikami S; Ochi F; Ujiie K; Nakamura Y; Takemura M; Yamaguchi A; Kakihara N; Ikawa O; Okano S
Gan To Kagaku Ryoho; 2021 Feb; 48(2):248-250. PubMed ID: 33597371
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes and risk factors of non-curative endoscopic submucosal dissection for early gastric cancer: a retrospective multicenter study in Zhejiang, China.
Jin CQ; Zhao J; Ding XY; Yu LL; Ye GL; Zhu XJ; Shen JW; Yang Y; Jin B; Zhang CL; Lv B
Front Oncol; 2023; 13():1225702. PubMed ID: 37854682
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of additional gastrectomy after noncurative endoscopic submucosal dissection for early gastric cancer.
Makimoto S; Mushiake Y; Takami T; Shintani H; Kataoka N; Yamaguchi T; Oura S
BMC Surg; 2022 Oct; 22(1):352. PubMed ID: 36183089
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic Submucosal Dissection and Teprenone for Early Gastric Cancer, With Evaluation of eCura Scoring System.
Zhang F; Luo H
Altern Ther Health Med; 2023 May; 29(4):218-223. PubMed ID: 36947657
[TBL] [Abstract][Full Text] [Related]
14. Is the eCura system useful for selecting patients who require radical surgery after noncurative endoscopic submucosal dissection for early gastric cancer? A comparative study.
Hatta W; Gotoda T; Oyama T; Kawata N; Takahashi A; Yoshifuku Y; Hoteya S; Nakagawa M; Hirano M; Esaki M; Matsuda M; Ohnita K; Yamanouchi K; Yoshida M; Dohi O; Takada J; Tanaka K; Yamada S; Tsuji T; Ito H; Hayashi Y; Nakamura T; Nakaya N; Shimosegawa T
Gastric Cancer; 2018 May; 21(3):481-489. PubMed ID: 28983696
[TBL] [Abstract][Full Text] [Related]
15. Is Additional Gastrectomy Required for Elderly Patients after Endoscopic Submucosal Dissection with Endoscopic Curability C-2 for Early Gastric Cancer?
Hatta W; Gotoda T; Koike T; Uno K; Asano N; Imatani A; Masamune A
Digestion; 2022; 103(1):83-91. PubMed ID: 34638125
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for lymph node metastasis and long-term outcomes of patients with early gastric cancer after non-curative endoscopic submucosal dissection.
Kawata N; Kakushima N; Takizawa K; Tanaka M; Makuuchi R; Tokunaga M; Tanizawa Y; Bando E; Kawamura T; Sugino T; Kusafuka K; Shimoda T; Nakajima T; Terashima M; Ono H
Surg Endosc; 2017 Apr; 31(4):1607-1616. PubMed ID: 27495338
[TBL] [Abstract][Full Text] [Related]
17. Optimal management for patients not meeting the inclusion criteria after endoscopic submucosal dissection for gastric cancer.
Toyokawa T; Ohira M; Tanaka H; Minamino H; Sakurai K; Nagami Y; Kubo N; Yamamoto A; Sano K; Muguruma K; Tominaga K; Nebiki H; Yamashita Y; Arakawa T; Hirakawa K
Surg Endosc; 2016 Jun; 30(6):2404-14. PubMed ID: 26463497
[TBL] [Abstract][Full Text] [Related]
18. Optimal extent of lymph node dissection in patients with gastric cancer who underwent non-curative endoscopic submucosal dissection with a positive vertical margin.
Furukawa K; Kamiya S; Sugino T; Aizawa D; Kawabata T; Notsu A; Hikage M; Tanizawa Y; Bando E; Takizawa K; Ono H; Terashima M
Eur J Surg Oncol; 2020 Dec; 46(12):2229-2235. PubMed ID: 32788095
[TBL] [Abstract][Full Text] [Related]
19. Factors related to lymph node metastasis and the feasibility of endoscopic mucosal resection for treating poorly differentiated adenocarcinoma of the stomach.
Park YD; Chung YJ; Chung HY; Yu W; Bae HI; Jeon SW; Cho CM; Tak WY; Kweon YO
Endoscopy; 2008 Jan; 40(1):7-10. PubMed ID: 18210339
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of minimally invasive treatment for early gastric cancer in patients beyond the indications of endoscopic submucosal dissection.
Ko WJ; Kim YM; Yoo IK; Cho JY
Surg Endosc; 2018 Sep; 32(9):3798-3805. PubMed ID: 29464402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
